 | • レポートコード：GIR-105X13846 • 出版社/出版日： / 2021年5月 • レポート形態：英文、PDF、131ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：Pharma & Healthcare |
| Single User | ￥515,040 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥772,560 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,030,080 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料では、肺サーファクタントのグローバル市場について調査・分析し、2021年から2026年までの市場予測をまとめております。肺サーファクタントの種類別市場規模（合成肺サーファクタント、動物由来界面活性剤）、用途別市場規模（病院、実験室、その他）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・肺サーファクタントの市場概要 ・企業情報（企業概要、製品概要、販売量、価格、売上）：Boehringer Ingelheim、AbbVie、Lyomark Pharma、Tekzima (Noargen)、ONY Biotech、Abbott、Aviva Systems Biology、LSBio、Biomatik、Biorbyt、Reddot Biotech、XpressBio、Creative Diagnostics、Nanjing Norris Pharm Technology、Windtree Therapeutics ・企業別市場シェア ・地域別市場分析2016年-2026年 ・種類別分析2016年-2026年：合成肺サーファクタント、動物由来界面活性剤 ・用途別分析2016年-2026年：病院、実験室、その他 ・肺サーファクタントの北米市場規模2016年-2026年：アメリカ、カナダ、メキシコ ・肺サーファクタントのヨーロッパ市場規模2016年-2026年：ドイツ、イギリス、フランス、ロシア、イタリア ・肺サーファクタントのアジア市場規模2016年-2026年：中国、日本、韓国、インド、東南アジア、オーストラリア ・肺サーファクタントの南米市場規模2016年-2026年：ブラジル、アルゼンチン ・肺サーファクタントの中東・アフリカ市場規模2016年-2026年：サウジアラビア、トルコ、エジプト、南アフリカ ・販売チャネル、流通業者・代理店、顧客リスト ・調査の結果・結論 |
The Pulmonary Surfactant market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our latest research, the global Pulmonary Surfactant size is estimated to be xx million in 2020 from USD xx million in 2019, with a change of XX% between 2019 and 2020. The global Pulmonary Surfactant market size is expected to grow at a CAGR of xx% for the next five years.
Market segmentation
Pulmonary Surfactant market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Synthetic Pulmonary Surfactants
Animal Derived Surfactants
Market segment by Application can be divided into
Hospital
laboratory
Others
The key market players for global Pulmonary Surfactant market are listed below:
Boehringer Ingelheim
AbbVie
Lyomark Pharma
Tekzima (Noargen)
ONY Biotech
Abbott
Aviva Systems Biology
LSBio
Biomatik
Biorbyt
Reddot Biotech
XpressBio
Creative Diagnostics
Nanjing Norris Pharm Technology
Windtree Therapeutics
Market segment by Region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
1 Market Overview
1.1 Pulmonary Surfactant Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Pulmonary Surfactant Revenue by Type: 2019 Versus 2021 Versus 2026
1.2.2 Synthetic Pulmonary Surfactants
1.2.3 Animal Derived Surfactants
1.3 Market Analysis by Application
1.3.1 Overview: Global Pulmonary Surfactant Revenue by Application: 2019 Versus 2021 Versus 2026
1.3.2 Hospital
1.3.3 laboratory
1.3.4 Others
1.4 Global Pulmonary Surfactant Market Size & Forecast
1.4.1 Global Pulmonary Surfactant Sales in Value (2016-2026))
1.4.2 Global Pulmonary Surfactant Sales in Volume (2016-2026)
1.4.3 Global Pulmonary Surfactant Price by Type (2016-2026) & (USD/Unit)
1.5 Global Pulmonary Surfactant Production Capacity Analysis
1.5.1 Global Pulmonary Surfactant Total Production Capacity (2016-2026)
1.5.2 Global Pulmonary Surfactant Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Pulmonary Surfactant Market Drivers
1.6.2 Pulmonary Surfactant Market Restraints
1.6.3 Pulmonary Surfactant Trends Analysis
2 Manufacturers Profiles
2.1 Boehringer Ingelheim
2.1.1 Boehringer Ingelheim Details
2.1.2 Boehringer Ingelheim Major Business
2.1.3 Boehringer Ingelheim Pulmonary Surfactant Product and Services
2.1.4 Boehringer Ingelheim Pulmonary Surfactant Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.2 AbbVie
2.2.1 AbbVie Details
2.2.2 AbbVie Major Business
2.2.3 AbbVie Pulmonary Surfactant Product and Services
2.2.4 AbbVie Pulmonary Surfactant Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.3 Lyomark Pharma
2.3.1 Lyomark Pharma Details
2.3.2 Lyomark Pharma Major Business
2.3.3 Lyomark Pharma Pulmonary Surfactant Product and Services
2.3.4 Lyomark Pharma Pulmonary Surfactant Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.4 Tekzima (Noargen)
2.4.1 Tekzima (Noargen) Details
2.4.2 Tekzima (Noargen) Major Business
2.4.3 Tekzima (Noargen) Pulmonary Surfactant Product and Services
2.4.4 Tekzima (Noargen) Pulmonary Surfactant Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.5 ONY Biotech
2.5.1 ONY Biotech Details
2.5.2 ONY Biotech Major Business
2.5.3 ONY Biotech Pulmonary Surfactant Product and Services
2.5.4 ONY Biotech Pulmonary Surfactant Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.6 Abbott
2.6.1 Abbott Details
2.6.2 Abbott Major Business
2.6.3 Abbott Pulmonary Surfactant Product and Services
2.6.4 Abbott Pulmonary Surfactant Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.7 Aviva Systems Biology
2.7.1 Aviva Systems Biology Details
2.7.2 Aviva Systems Biology Major Business
2.7.3 Aviva Systems Biology Pulmonary Surfactant Product and Services
2.7.4 Aviva Systems Biology Pulmonary Surfactant Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.8 LSBio
2.8.1 LSBio Details
2.8.2 LSBio Major Business
2.8.3 LSBio Pulmonary Surfactant Product and Services
2.8.4 LSBio Pulmonary Surfactant Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.9 Biomatik
2.9.1 Biomatik Details
2.9.2 Biomatik Major Business
2.9.3 Biomatik Pulmonary Surfactant Product and Services
2.9.4 Biomatik Pulmonary Surfactant Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.10 Biorbyt
2.10.1 Biorbyt Details
2.10.2 Biorbyt Major Business
2.10.3 Biorbyt Pulmonary Surfactant Product and Services
2.10.4 Biorbyt Pulmonary Surfactant Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.11 Reddot Biotech
2.11.1 Reddot Biotech Details
2.11.2 Reddot Biotech Major Business
2.11.3 Reddot Biotech Pulmonary Surfactant Product and Services
2.11.4 Reddot Biotech Pulmonary Surfactant Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.12 XpressBio
2.12.1 XpressBio Details
2.12.2 XpressBio Major Business
2.12.3 XpressBio Pulmonary Surfactant Product and Services
2.12.4 XpressBio Pulmonary Surfactant Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.13 Creative Diagnostics
2.13.1 Creative Diagnostics Details
2.13.2 Creative Diagnostics Major Business
2.13.3 Creative Diagnostics Pulmonary Surfactant Product and Services
2.13.4 Creative Diagnostics Pulmonary Surfactant Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.14 Nanjing Norris Pharm Technology
2.14.1 Nanjing Norris Pharm Technology Details
2.14.2 Nanjing Norris Pharm Technology Major Business
2.14.3 Nanjing Norris Pharm Technology Pulmonary Surfactant Product and Services
2.14.4 Nanjing Norris Pharm Technology Pulmonary Surfactant Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.15 Windtree Therapeutics
2.15.1 Windtree Therapeutics Details
2.15.2 Windtree Therapeutics Major Business
2.15.3 Windtree Therapeutics Pulmonary Surfactant Product and Services
2.15.4 Windtree Therapeutics Pulmonary Surfactant Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
3 Pulmonary Surfactant Sales by Manufacturer
3.1 Global Pulmonary Surfactant Sales in Volume by Manufacturer (2019-2021e)
3.2 Global Pulmonary Surfactant Revenue by Manufacturer (2019-2021e)
3.3 Key Manufacturer Market Position in Pulmonary Surfactant
3.4 Market Concentration Rate
3.4.1 Top 3 Pulmonary Surfactant Manufacturer Market Share
3.4.2 Top 6 Pulmonary Surfactant Manufacturer Market Share
3.5 Global Pulmonary Surfactant Production Capacity by Company
3.6 Manufacturer by Geography: Head Office and Pulmonary Surfactant Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Pulmonary Surfactant Market Size by Region
4.1.1 Global Pulmonary Surfactant Sales in Volume by Region (2016-2026)
4.1.2 Global Pulmonary Surfactant Revenue by Region (2016-2026)
4.2 North America Pulmonary Surfactant Revenue (2016-2026)
4.3 Europe Pulmonary Surfactant Revenue (2016-2026)
4.4 Asia-Pacific Pulmonary Surfactant Revenue (2016-2026)
4.5 South America Pulmonary Surfactant Revenue (2016-2026)
4.6 Middle East and Africa Pulmonary Surfactant Revenue (2016-2026)
5 Market Segment by Type
5.1 Global Pulmonary Surfactant Sales in Volume by Type (2016-2026)
5.2 Global Pulmonary Surfactant Revenue by Type (2016-2026)
5.3 Global Pulmonary Surfactant Price by Type (2016-2026)
6 Market Segment by Application
6.1 Global Pulmonary Surfactant Sales in Volume by Application (2016-2026)
6.2 Global Pulmonary Surfactant Revenue by Application (2016-2026)
6.3 Global Pulmonary Surfactant Price by Application (2016-2026)
7 North America by Country, by Type, and by Application
7.1 North America Pulmonary Surfactant Sales by Type (2016-2026)
7.2 North America Pulmonary Surfactant Sales by Application (2016-2026)
7.3 North America Pulmonary Surfactant Market Size by Country
7.3.1 North America Pulmonary Surfactant Sales in Volume by Country (2016-2026)
7.3.2 North America Pulmonary Surfactant Revenue by Country (2016-2026)
7.3.3 United States Market Size and Forecast (2016-2026)
7.3.4 Canada Market Size and Forecast (2016-2026)
7.3.5 Mexico Market Size and Forecast (2016-2026)
8 Europe by Country, by Type, and by Application
8.1 Europe Pulmonary Surfactant Sales by Type (2016-2026)
8.2 Europe Pulmonary Surfactant Sales by Application (2016-2026)
8.3 Europe Pulmonary Surfactant Market Size by Country
8.3.1 Europe Pulmonary Surfactant Sales in Volume by Country (2016-2026)
8.3.2 Europe Pulmonary Surfactant Revenue by Country (2016-2026)
8.3.3 Germany Market Size and Forecast (2016-2026)
8.3.4 France Market Size and Forecast (2016-2026)
8.3.5 United Kingdom Market Size and Forecast (2016-2026)
8.3.6 Russia Market Size and Forecast (2016-2026)
8.3.7 Italy Market Size and Forecast (2016-2026)
9 Asia-Pacific by Country, by Type, and by Application
9.1 Asia-Pacific Pulmonary Surfactant Sales by Type (2016-2026)
9.2 Asia-Pacific Pulmonary Surfactant Sales by Application (2016-2026)
9.3 Asia-Pacific Pulmonary Surfactant Market Size by Region
9.3.1 Asia-Pacific Pulmonary Surfactant Sales in Volume by Region (2016-2026)
9.3.2 Asia-Pacific Pulmonary Surfactant Revenue by Region (2016-2026)
9.3.3 China Market Size and Forecast (2016-2026)
9.3.4 Japan Market Size and Forecast (2016-2026)
9.3.5 Korea Market Size and Forecast (2016-2026)
9.3.6 India Market Size and Forecast (2016-2026)
9.3.7 Southeast Asia Market Size and Forecast (2016-2026)
9.3.8 Australia Market Size and Forecast (2016-2026)
10 South America by Country, by Type, and by Application
10.1 South America Pulmonary Surfactant Sales by Type (2016-2026)
10.2 South America Pulmonary Surfactant Sales by Application (2016-2026)
10.3 South America Pulmonary Surfactant Market Size by Country
10.3.1 South America Pulmonary Surfactant Sales in Volume by Country (2016-2026)
10.3.2 South America Pulmonary Surfactant Revenue by Country (2016-2026)
10.3.3 Brazil Market Size and Forecast (2016-2026)
10.3.4 Argentina Market Size and Forecast (2016-2026)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Pulmonary Surfactant Sales by Type (2016-2026)
11.2 Middle East & Africa Pulmonary Surfactant Sales by Application (2016-2026)
11.3 Middle East & Africa Pulmonary Surfactant Market Size by Country
11.3.1 Middle East & Africa Pulmonary Surfactant Sales in Volume by Country (2016-2026)
11.3.2 Middle East & Africa Pulmonary Surfactant Revenue by Country (2016-2026)
11.3.3 Turkey Market Size and Forecast (2016-2026)
11.3.4 Egypt Market Size and Forecast (2016-2026)
11.3.5 Saudi Arabia Market Size and Forecast (2016-2026)
11.3.6 South Africa Market Size and Forecast (2016-2026)
12 Sales Channel, Distributors, Traders and Dealers
12.1 Sales Channel
12.1.1 Direct Marketing
12.1.2 Indirect Marketing
12.2 Pulmonary Surfactant Typical Distributors
12.3 Pulmonary Surfactant Typical Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
Table 1. Global Pulmonary Surfactant Revenue by Type, (USD Million), 2021-2026
Table 2. Global Pulmonary Surfactant Revenue by Application, (USD Million), 2021-2026
Table 3. Boehringer Ingelheim Basic Information, Manufacturing Base and Competitors
Table 4. Boehringer Ingelheim Major Business
Table 5. Boehringer Ingelheim Pulmonary Surfactant Product and Services
Table 6. Boehringer Ingelheim Pulmonary Surfactant Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 7. AbbVie Basic Information, Manufacturing Base and Competitors
Table 8. AbbVie Major Business
Table 9. AbbVie Pulmonary Surfactant Product and Services
Table 10. AbbVie Pulmonary Surfactant Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 11. Lyomark Pharma Basic Information, Manufacturing Base and Competitors
Table 12. Lyomark Pharma Major Business
Table 13. Lyomark Pharma Pulmonary Surfactant Product and Services
Table 14. Lyomark Pharma Pulmonary Surfactant Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 15. Tekzima (Noargen) Basic Information, Manufacturing Base and Competitors
Table 16. Tekzima (Noargen) Major Business
Table 17. Tekzima (Noargen) Pulmonary Surfactant Product and Services
Table 18. Tekzima (Noargen) Pulmonary Surfactant Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 19. ONY Biotech Basic Information, Manufacturing Base and Competitors
Table 20. ONY Biotech Major Business
Table 21. ONY Biotech Pulmonary Surfactant Product and Services
Table 22. ONY Biotech Pulmonary Surfactant Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 23. Abbott Basic Information, Manufacturing Base and Competitors
Table 24. Abbott Major Business
Table 25. Abbott Pulmonary Surfactant Product and Services
Table 26. Abbott Pulmonary Surfactant Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 27. Aviva Systems Biology Basic Information, Manufacturing Base and Competitors
Table 28. Aviva Systems Biology Major Business
Table 29. Aviva Systems Biology Pulmonary Surfactant Product and Services
Table 30. Aviva Systems Biology Pulmonary Surfactant Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 31. LSBio Basic Information, Manufacturing Base and Competitors
Table 32. LSBio Major Business
Table 33. LSBio Pulmonary Surfactant Product and Services
Table 34. LSBio Pulmonary Surfactant Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 35. Biomatik Basic Information, Manufacturing Base and Competitors
Table 36. Biomatik Major Business
Table 37. Biomatik Pulmonary Surfactant Product and Services
Table 38. Biomatik Pulmonary Surfactant Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 39. Biorbyt Basic Information, Manufacturing Base and Competitors
Table 40. Biorbyt Major Business
Table 41. Biorbyt Pulmonary Surfactant Product and Services
Table 42. Biorbyt Pulmonary Surfactant Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 43. Reddot Biotech Basic Information, Manufacturing Base and Competitors
Table 44. Reddot Biotech Major Business
Table 45. Reddot Biotech Pulmonary Surfactant Product and Services
Table 46. Reddot Biotech Pulmonary Surfactant Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 47. XpressBio Basic Information, Manufacturing Base and Competitors
Table 48. XpressBio Major Business
Table 49. XpressBio Pulmonary Surfactant Product and Services
Table 50. XpressBio Pulmonary Surfactant Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 51. Creative Diagnostics Basic Information, Manufacturing Base and Competitors
Table 52. Creative Diagnostics Major Business
Table 53. Creative Diagnostics Pulmonary Surfactant Product and Services
Table 54. Creative Diagnostics Pulmonary Surfactant Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 55. Nanjing Norris Pharm Technology Basic Information, Manufacturing Base and Competitors
Table 56. Nanjing Norris Pharm Technology Major Business
Table 57. Nanjing Norris Pharm Technology Pulmonary Surfactant Product and Services
Table 58. Nanjing Norris Pharm Technology Pulmonary Surfactant Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 59. Windtree Therapeutics Basic Information, Manufacturing Base and Competitors
Table 60. Windtree Therapeutics Major Business
Table 61. Windtree Therapeutics Pulmonary Surfactant Product and Services
Table 62. Windtree Therapeutics Pulmonary Surfactant Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 63. Global Pulmonary Surfactant Sales by Manufacturer (2019-2021e) & (K Units)
Table 64. Global Pulmonary Surfactant Revenue by Manufacturer (2019-2021e) & (USD Million)
Table 65. Market Position of Manufacturers in Pulmonary Surfactant, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2020
Table 66. Global Pulmonary Surfactant Production Capacity by Company, (K Units): 2020 VS 2021
Table 67. Head Office and Pulmonary Surfactant Production Site of Key Manufacturer
Table 68. Global Pulmonary Surfactant Sales by Region (2016-2021e) & (K Units)
Table 69. Global Pulmonary Surfactant Sales by Region (2021-2026) & (K Units)
Table 70. Global Pulmonary Surfactant Revenue by Region (2016-2021e) & (USD Million)
Table 71. Global Pulmonary Surfactant Revenue by Region (2021-2026) & (USD Million)
Table 72. Global Pulmonary Surfactant Sales by Type (2016-2021e) & (K Units)
Table 73. Global Pulmonary Surfactant Sales by Type (2021-2026) & (K Units)
Table 74. Global Pulmonary Surfactant Revenue by Type (2016-2021e) & (USD Million)
Table 75. Global Pulmonary Surfactant Revenue by Type (2021-2026) & (USD Million)
Table 76. Global Pulmonary Surfactant Price by Type (2016-2021e) & (USD/Unit)
Table 77. Global Pulmonary Surfactant Price by Type (2021-2026) & (USD/Unit)
Table 78. Global Pulmonary Surfactant Sales by Application (2016-2021e) & (K Units)
Table 79. Global Pulmonary Surfactant Sales by Application (2021-2026) & (K Units)
Table 80. Global Pulmonary Surfactant Revenue by Application (2016-2021e) & (USD Million)
Table 81. Global Pulmonary Surfactant Revenue by Application (2021-2026) & (USD Million)
Table 82. Global Pulmonary Surfactant Price by Application (2016-2021e) & (USD/Unit)
Table 83. Global Pulmonary Surfactant Price by Application (2021-2026) & (USD/Unit)
Table 84. North America Pulmonary Surfactant Sales by Country (2016-2021e) & (K Units)
Table 85. North America Pulmonary Surfactant Sales by Country (2021-2026) & (K Units)
Table 86. North America Pulmonary Surfactant Revenue by Country (2016-2021e) & (USD Million)
Table 87. North America Pulmonary Surfactant Revenue by Country (2021-2026) & (USD Million)
Table 88. North America Pulmonary Surfactant Sales by Type (2016-2021e) & (K Units)
Table 89. North America Pulmonary Surfactant Sales by Type (2021-2026) & (K Units)
Table 90. North America Pulmonary Surfactant Sales by Application (2016-2021e) & (K Units)
Table 91. North America Pulmonary Surfactant Sales by Application (2021-2026) & (K Units)
Table 92. Europe Pulmonary Surfactant Sales by Country (2016-2021e) & (K Units)
Table 93. Europe Pulmonary Surfactant Sales by Country (2021-2026) & (K Units)
Table 94. Europe Pulmonary Surfactant Revenue by Country (2016-2021e) & (USD Million)
Table 95. Europe Pulmonary Surfactant Revenue by Country (2021-2026) & (USD Million)
Table 96. Europe Pulmonary Surfactant Sales by Type (2016-2021e) & (K Units)
Table 97. Europe Pulmonary Surfactant Sales by Type (2021-2026) & (K Units)
Table 98. Europe Pulmonary Surfactant Sales by Application (2016-2021e) & (K Units)
Table 99. Europe Pulmonary Surfactant Sales by Application (2021-2026) & (K Units)
Table 100. Asia-Pacific Pulmonary Surfactant Sales by Region (2016-2021e) & (K Units)
Table 101. Asia-Pacific Pulmonary Surfactant Sales by Region (2021-2026) & (K Units)
Table 102. Asia-Pacific Pulmonary Surfactant Revenue by Region (2016-2021e) & (USD Million)
Table 103. Asia-Pacific Pulmonary Surfactant Revenue by Region (2021-2026) & (USD Million)
Table 104. Asia-Pacific Pulmonary Surfactant Sales by Type (2016-2021e) & (K Units)
Table 105. Asia-Pacific Pulmonary Surfactant Sales by Type (2021-2026) & (K Units)
Table 106. Asia-Pacific Pulmonary Surfactant Sales by Application (2016-2021e) & (K Units)
Table 107. Asia-Pacific Pulmonary Surfactant Sales by Application (2021-2026) & (K Units)
Table 108. South America Pulmonary Surfactant Sales by Country (2016-2021e) & (K Units)
Table 109. South America Pulmonary Surfactant Sales by Country (2021-2026) & (K Units)
Table 110. South America Pulmonary Surfactant Revenue by Country (2016-2021e) & (USD Million)
Table 111. South America Pulmonary Surfactant Revenue by Country (2021-2026) & (USD Million)
Table 112. South America Pulmonary Surfactant Sales by Type (2016-2021e) & (K Units)
Table 113. South America Pulmonary Surfactant Sales by Type (2021-2026) & (K Units)
Table 114. South America Pulmonary Surfactant Sales by Application (2016-2021e) & (K Units)
Table 115. South America Pulmonary Surfactant Sales by Application (2021-2026) & (K Units)
Table 116. Middle East & Africa Pulmonary Surfactant Sales by Country (2016-2021e) & (K Units)
Table 117. Middle East & Africa Pulmonary Surfactant Sales by Country (2021-2026) & (K Units)
Table 118. Middle East & Africa Pulmonary Surfactant Revenue by Country (2016-2021e) & (USD Million)
Table 119. Middle East & Africa Pulmonary Surfactant Revenue by Country (2021-2026) & (USD Million)
Table 120. Middle East & Africa Pulmonary Surfactant Sales by Type (2016-2021e) & (K Units)
Table 121. Middle East & Africa Pulmonary Surfactant Sales by Type (2021-2026) & (K Units)
Table 122. Middle East & Africa Pulmonary Surfactant Sales by Application (2016-2021e) & (K Units)
Table 123. Middle East & Africa Pulmonary Surfactant Sales by Application (2021-2026) & (K Units)
Table 124. Direct Channel Pros & Cons
Table 125. Indirect Channel Pros & Cons
Table 126. Pulmonary Surfactant Typical Distributors
Table 127. Pulmonary Surfactant Typical Customers
List of Figures
Figure 1. Pulmonary Surfactant Picture
Figure 2. Global Pulmonary Surfactant Sales Market Share by Type in 2020
Figure 3. Synthetic Pulmonary Surfactants
Figure 4. Animal Derived Surfactants
Figure 5. Global Pulmonary Surfactant Sales Market Share by Application in 2020
Figure 6. Hospital
Figure 7. laboratory
Figure 8. Others
Figure 9. Global Pulmonary Surfactant Market Size, (USD Million) & (K Units): 2020 VS 2021 VS 2026
Figure 10. Global Pulmonary Surfactant Market Size and Forecast (2016-2026) & (USD Million)
Figure 11. United States Pulmonary Surfactant Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 12. Canada Pulmonary Surfactant Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 13. Mexico Pulmonary Surfactant Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 14. Germany Pulmonary Surfactant Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 15. France Pulmonary Surfactant Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 16. United Kingdom Pulmonary Surfactant Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 17. Russia Pulmonary Surfactant Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 18. Italy Pulmonary Surfactant Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 19. China Pulmonary Surfactant Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 20. Japan Pulmonary Surfactant Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 21. Korea Pulmonary Surfactant Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 22. India Pulmonary Surfactant Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 23. Southeast Asia Pulmonary Surfactant Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 24. Australia Pulmonary Surfactant Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 25. Brazil Pulmonary Surfactant Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 26. Egypt Pulmonary Surfactant Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 27. Saudi Arabia Pulmonary Surfactant Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 28. South Africa Pulmonary Surfactant Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 29. Turkey Pulmonary Surfactant Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 30. Global Pulmonary Surfactant Sales (2016-2026) & (K Units)
Figure 31. Global Pulmonary Surfactant Production Capacity (2016-2026) & (K Units)
Figure 32. Global Pulmonary Surfactant Production Capacity by Geographic Region: 2020 VS 2021
Figure 33. Pulmonary Surfactant Market Drivers
Figure 34. Pulmonary Surfactant Market Restraints
Figure 35. Pulmonary Surfactant Market Trends
Figure 36. Global Pulmonary Surfactant Sales Market Share by Manufacturer in 2020
Figure 37. Global Pulmonary Surfactant Revenue Market Share by Manufacturer in 2020
Figure 38. Pulmonary Surfactant Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
Figure 39. Top 3 Pulmonary Surfactant Manufacturer (Revenue) Market Share in 2020
Figure 40. Top 6 Pulmonary Surfactant Manufacturer (Revenue) Market Share in 2020
Figure 41. Global Pulmonary Surfactant Sales Market Share by Region (2016-2026)
Figure 42. Global Pulmonary Surfactant Revenue Market Share by Region (2016-2026)
Figure 43. North America Pulmonary Surfactant Revenue (2016-2026) & (USD Million)
Figure 44. Europe Pulmonary Surfactant Revenue (2016-2026) & (USD Million)
Figure 45. Asia-Pacific Pulmonary Surfactant Revenue (2016-2026) & (USD Million)
Figure 46. South America Pulmonary Surfactant Revenue (2016-2026) & (USD Million)
Figure 47. Middle East & Africa Pulmonary Surfactant Revenue (2016-2026) & (USD Million)
Figure 48. Global Pulmonary Surfactant Sales Market Share by Type (2016-2026)
Figure 49. Global Pulmonary Surfactant Revenue Market Share by Type (2016-2026)
Figure 50. Global Pulmonary Surfactant Price by Type (2016-2026) & (USD/Unit)
Figure 51. Global Pulmonary Surfactant Sales Market Share by Application (2016-2026)
Figure 52. Global Pulmonary Surfactant Revenue Market Share by Application (2016-2026)
Figure 53. Global Pulmonary Surfactant Price by Application (2016-2026) & (USD/Unit)
Figure 54. North America Pulmonary Surfactant Sales Market Share by Country (2016-2026)
Figure 55. North America Pulmonary Surfactant Revenue Market Share by Country (2016-2026)
Figure 56. North America Pulmonary Surfactant Sales Market Share by Type (2016-2026)
Figure 57. North America Pulmonary Surfactant Sales Market Share by Application (2016-2026)
Figure 58. Europe Pulmonary Surfactant Sales Market Share by Country (2016-2026)
Figure 59. Europe Pulmonary Surfactant Revenue Market Share by Country (2016-2026)
Figure 60. Europe Pulmonary Surfactant Sales Market Share by Type (2016-2026)
Figure 61. Europe Pulmonary Surfactant Sales Market Share by Application (2016-2026)
Figure 62. Asia-Pacific Pulmonary Surfactant Sales Market Share by Region (2016-2026)
Figure 63. Asia-Pacific Pulmonary Surfactant Revenue Market Share by Region (2016-2026)
Figure 64. Asia-Pacific Pulmonary Surfactant Sales Market Share by Region (2016-2026)
Figure 65. Asia-Pacific Pulmonary Surfactant Sales Market Share by Application (2016-2026)
Figure 66. South America Pulmonary Surfactant Sales Market Share by Country (2016-2026)
Figure 67. South America Pulmonary Surfactant Revenue Market Share by Country (2016-2026)
Figure 68. South America Pulmonary Surfactant Sales Market Share by Type (2016-2026)
Figure 69. South America Pulmonary Surfactant Sales Market Share by Application (2016-2026)
Figure 70. Middle East & Africa Pulmonary Surfactant Sales Market Share by Country (2016-2026)
Figure 71. Middle East & Africa Pulmonary Surfactant Revenue Market Share by Country (2016-2026)
Figure 72. Middle East & Africa Pulmonary Surfactant Sales Market Share by Type (2016-2026)
Figure 73. Middle East & Africa Pulmonary Surfactant Sales Market Share by Application (2016-2026)
Figure 74. Sales Channel: Direct Channel vs Indirect Channel
Figure 75. Methodology
Figure 76. Research Process and Data Source
慢性閉塞性肺疾患の世界市場予測 2023年：メーカー別、地域別、種類・用途別 Chronic obstructive pulmonary disease (COPD) is a type of obstructive lung disease characterized by long-term breathing problems and poor airflow The main symptoms include shortness of breath and cough with sputum production. COPD is a progressive disease, meaning it typically worsens over time. Eve…- 特発性肺線維症の世界市場予測 2023年：メーカー別、地域別、種類・用途別 Idiopathic pulmonary fibrosis is a condition in which the tissues in the lungs become thick and stiff over time. As a result of thickening of lung tissues, brain and other organs are unable receive optimum oxygen. Scope of the Report: This report studies the Idiopathic Pulmonary Fibrosis market stat…
- 肺動脈カテーテルの世界市場2018-2025 This study researches the market size of Pulmonary Artery Catheter, presents the global Pulmonary Artery Catheter sales and revenue by companies, regions, type and application, history breakdown data from 2013 to 2018, and forecast to 2025.This report focuses on the key data information of Pulmonary…
- 慢性閉塞性肺動脈の病気トリートメントの世界市場2018-2025 In 2018, the global Chronic Obstructive Pulmonary Disease Treatment market size was million US$ and is forecast to million US in 2025, growing at a CAGR of from 2018. In this study, 2017 has been considered as the base year and 2018 to 2025 as the forecast period to estimate the market size for Chro…
- 肺デバイスの世界市場予測 2023年：メーカー別、地域別、種類・用途別 Pulmonary or respiratory devices are used to remove mucus and secretions from the airways or the respiratory tract. Scope of the Report: This report focuses on the Pulmonary Devices in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This r…